Beta Bionics Stock Guidance | NASDAQ:BBNX

Comments

Beta Bionics Inc Stock Guidance

BBNXNASDAQ

Trade with Public

$9.73

-0.22-2.21%

At close: Apr 7, 5:00 PM EST

$9.92

0.191.95%

After Hours: 5:28 PM EST

Earnings: Q1 2026 Earnings in 14 days from now on Tue Apr 21st, after the market close

Overview News Earnings OptionsGuidanceAnalyst Ratings Insider Trades Short Interest Stock Report

Beta Bionics (BBNX) last issued guidance on February 17, 2026 for fiscal year 2026. The company guided revenue in the range of $130.00M - $135.00M for the period.

Compared to prior guidance, Beta Bionics raised its revenue forecast from a prior range of $88.00M - $93.00M.

Beta Bionics has issued 4 guidance updates between March 25, 2025 and February 17, 2026. During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.

Latest Guidance Date

Feb 17, 2026

Guidance Period

Full Year 2026

Revenue Guidance Range

$130.00M - $135.00M

Beta Bionics Guidance History

Review all historical guidance issued by Beta Bionics, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

What is the most recent guidance for Beta Bionics (BBNX)?

The most recent guidance for Beta Bionics (BBNX) was reported on February 17, 2026 for the fiscal year 2026. Beta Bionics forecasted revenue between $130.00M and $135.00M for the period.

What revenue range did Beta Bionics (BBNX) guide for?

Beta Bionics (BBNX) guided revenue in the range of $130.00M to $135.00M for the fiscal year 2026.

Did Beta Bionics (BBNX) raise or lower guidance?

Beta Bionics (BBNX) raised its revenue guidance from a prior range of $88.00M - $93.00M to $130.00M - $135.00M for the fiscal year 2026.

When did Beta Bionics (BBNX) last issue guidance?

Beta Bionics (BBNX) last issued guidance on February 17, 2026 for the fiscal year 2026.

People Also Watch